Authors of a recent editorial appearing in the Journal of the National Cancer Institute say opening clinical trials in ...

什么是“懒癌”？所谓的懒癌，其实是指那些生长发展慢的恶性肿瘤（癌症）。今天要说的是其中的一个典型代表：滤泡性淋巴瘤。 滤泡性淋巴瘤（follicular lymphoma，FL）是起源于滤泡中心B细胞的淋巴瘤，是第二常见的非霍奇金淋巴瘤，也是最常见的低度恶性B ...

(RTTNews) - AbbVie (ABBV) announced that the European Commission has granted conditional marketing authorization for Tepkinly (epcoritamab) as a monotherapy for the treatment of adult patients with ...

Gastrointestinal follicular lymphoma (GI‐FL) is a rare, indolent B‐cell neoplasm that predominantly affects the small intestine, particularly the duodenum, although cases have been reported throughout ...

Acalabrutinib combined with lenalidomide and rituximab shows promising results as a frontline treatment for follicular lymphoma, achieving high response rates.

Jessica Farrington shared the signs of cancer that she ignored before being diagnosed with non-Hodgkin follicular lymphoma.

To confirm a diagnosis and determine the stage of the disease, your doctor will use a series of tests: Biopsy: This is the most definitive test. A surgeon will remove all or part of an affected lymph ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a new collaboration with the ...

Results showed an overall response rate of 82%; 60% of patients achieved complete response and 22% achieved partial response. The Food and Drug Administration (FDA) has granted accelerated approval to ...

Verismo Therapeutics, a clinical-stage CAR T company developing novel KIR-CAR platform technology, today announced that it ...

Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades. Yet up to 20% of patients develop early progression after starting ...